Latest Advances

  • Condition: Locally Advanced Pancreatic Cancer
  • Journal: The lancet. Gastroenterology & hepatology
  • Treatment Used: Nab-Paclitaxel plus Gemcitabine versus Nab-Paclitaxel plus Gemcitabine followed by FOLFIRINOX Induction Chemotherapy
  • Number of Patients: 168
  • Published —
The study researched the outcomes of nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy for treating locally advanced pancreatic cancer.
  • Condition: Obstructive Jaundice
  • Journal: The Nigerian postgraduate medical journal
  • Treatment Used: Endoscopic Retrograde Cholangiopancreatography
  • Number of Patients: 177
  • Published —
In this study, researchers evaluated the outcomes of undergoing endoscopic retrograde cholangiopancreatography for the treatment of obstructive jaundice.
  • Condition: Refractory Hepatolithiasis
  • Journal: World journal of gastroenterology
  • Treatment Used: Modified Percutaneous Transhepatic Papillary Balloon Dilation
  • Number of Patients: 21
  • Published —
The study researched the outcomes of modified percutaneous transhepatic papillary balloon dilation for patients with refractory hepatolithiasis.
  • Condition: Chronic Hepatitis
  • Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)
  • Treatment Used: Therapeutic Plasmapheresis
  • Number of Patients: 77
  • Published —
In this study, researchers evaluated the outcomes of using therapeutic plasmapheresis as part of a complex treatment regimen for chronic hepatitis.
  • Condition: Recurrent Ascending Cholangitis with Acute Pancreatitis and Pancreatic Atrophy caused by Juxtapapillary Duodenal Diverticulum
  • Journal: Medicine
  • Treatment Used: Open Transduodenal Sphincteroplasty and Septoplasty
  • Number of Patients: 1
  • Published —
This case report describes a patient with recurrent ascending cholangitis with acute pancreatitis and pancreatic atrophy that was caused by a juxtapapillary duodenal diverticulum.
  • Condition: Intrahepatic cholestasis
  • Journal: BMJ case reports
  • Treatment Used: Odevixibat and invasive partial external biliary diversion
  • Number of Patients: 1
  • Published —
The study compared the use between odevixibat and invasive partial external biliary diversion for patients with intrahepatic cholestasis.
  • Condition: Malignant Obstruction
  • Journal: BMC gastroenterology
  • Treatment Used: Uncovered Biliary Stent
  • Number of Patients: 113
  • Published —
This study evaluated a newly designed uncovered biliary stent (used to to open the blocked bile duct) for palliation (treat as much as possible) of malignant obstruction.
  • Condition: Consumptive Hypothyroidism in a 1-Month-Old Boy with Diffuse Infantile Hepatic Hemangiomas
  • Journal: Journal of Korean medical science
  • Treatment Used: Higher-than-Usual Doses of Levothyroxine, Propranolol, and Prednisolone
  • Number of Patients: 1
  • Published —
This case report describes a 1-month-old boy with infantile hepatic hemangiomas and consumptive hypothyroidism treated with higher-than-usual doses of levothyroxine and propranolol and prednisolone.
  • Condition: Malignant Hilar Biliary Obstruction
  • Journal: BMC gastroenterology
  • Treatment Used: Side-by-side Versus Stent-in-stent Percutaneous Stent Placement
  • Number of Patients: 65
  • Published —
In this study, researchers compared the effectiveness of side-by-side versus stent-in-stent percutaneous stent placement for the treatment of malignant hilar biliary obstruction.
  • Condition: Prevention of Biliary Stent Occlusion for Obstructive Jaundice
  • Journal: Khirurgiia
  • Treatment Used: Different Stents
  • Number of Patients: 0
  • Published —
This article discusses the prevention of biliary stent occlusion.
  • Condition: Primary Sclerosing Cholangitis (PSC) and Primary Biliary Cholangitis (PBC)
  • Journal: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
  • Treatment Used: Ursodeoxycholic acid or Obeticholic Acid
  • Number of Patients: 0
  • Published —
This article discusses the diagnosis and treatment of primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) immune-mediated chronic liver diseases.
Showing 1-12 of 99